Literature DB >> 8423721

Giant extra-adrenal pheochromocytoma: magnetic resonance imaging with gadolinium-DTPA enhancement.

M R Terk1, H de Verdier, P M Colletti.   

Abstract

A case report of a 35-yr-old male presenting with moderate hypertension and a giant extra-adrenal pheochromocytoma is discussed. The patient was treated by chemotherapy and surgery with regression of the lesion and clinical relief of symptoms. Initial magnetic resonance imaging (MRI) with gadolinium-DTPA enhancement revealed a large complex pelvic mass. Follow-up examination following chemotherapy three months later demonstrated partial regression. The MRI findings and the pattern of gadolinium-DTPA enhancement are discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8423721     DOI: 10.1016/0730-725x(93)90410-f

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  5 in total

1.  Undiagnosed giant cystic pheochromocytoma: A case report.

Authors:  Huan-Liang Wang; Bao-Zhu Sun; Zhi-Jie Xu; Wei-Fu Lei; Xiao-Shuang Wang
Journal:  Oncol Lett       Date:  2015-07-10       Impact factor: 2.967

2.  A giant cystic pheochromocytoma of the adrenal gland.

Authors:  Zenggang Pan; Susan Repertinger; Caishu Deng; Poonam Sharma
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

3.  Giant Cystic Pheochromocytoma with Low Risk of Malignancy: A Case Report and Literature Review.

Authors:  Ravi Maharaj; Sangeeta Parbhu; Wesley Ramcharan; Shanta Baijoo; Wesley Greaves; Dave Harnanan; Wayne A Warner
Journal:  Case Rep Oncol Med       Date:  2017-03-15

4.  Undiagnosed Pheochromocytoma Presenting as a Pancreatic Tumor: A Case Report.

Authors:  Malgorzata Emilia Legocka; Sadegh Toutounchi; Ryszard Pogorzelski; Ewa Krajewska; Krzysztof Celejewski; Zbigniew Galazka
Journal:  Open Med (Wars)       Date:  2020-02-20

5.  Case report: Significant liver atrophy due to giant cystic pheochromocytoma.

Authors:  Qingbo Feng; Hancong Li; Guoteng Qiu; Zhaolun Cai; Jiaxin Li; Yong Zeng; Jiwei Huang
Journal:  Front Oncol       Date:  2022-08-30       Impact factor: 5.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.